#fda 2014

DAPAGLIFLOZIN, BMS-512148 ダパグリフロジン; (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, Cas 461432-26-8 Molecular Formula: C21H25ClO6Molecular Weight: 408.87 Dapagliflozin propandiol monohydrate; 960404-48-2 Molecular Weight502.98FormulaC21H25ClO6•C3H8O2•H2O Bristol-Myers Squibb (Originator)AstraZeneca TYPE 2 DIABETES,SGLT-2…

Naloxegol Movantik; NKTR-118; NKTR118; UNII-44T7335BKE; NKTR 118 854601-70-0  cas 1354744-91-4 (Naloxegol Oxalate) (4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol MF C34H53NO11 MW 651.78472 g/mol Morphinan-3,14-diol,…

Belinostat (PXD101), a novel HDAC inhibitor

Belinostat (PXD101)  FAST TRACK FDA , ORPHAN STATUS PXD101;PX105684;PXD-101;PXD 101;PX-105684 UNII:F4H96P17NZ N-Hydroxy-3-(3-phenylsulphamoylphenyl)acrylamide N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE NSC726630 (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide 414864-00-9 [RN] 866323-14-0 [RN] Beleodaq® Approved by…

FDA gives green light to Novartis acromegaly drug

Regulators in the USA has approved a long-acting release of Novartis’ Signifor as a treatment for acromegaly.

The Food and Drug Administration has approved Signifor LAR (pasireotide) for the treatment of patients with acromegaly who have had an inadequate response to surgery or for whom the latter is not an option. The thumbs-up comes a month after the European Medicines Agency approved the drug,…

FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV

FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV 12/10/2014 01:39 PM EST

  The U.S. Food and Drug Administration today approved Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the prevention of certain diseases caused by nine types of Human Papillomavirus (HPV). Covering nine HPV types, five more HPV types than Gardasil…

尼达尼布 ニンテダニブ NINTEDANIB For Idiopathic pulmonary fibrosis

NINTEDANIB, BBIF 1120, Intedanib

Boehringer Ingelheim Corp

As a potential treatment for a range of different solid tumour types CAS 656247-17-5 1377321-64-6 (nintedanib bisethanesulfonate) 3(Z)-[1-[4-[N-Methyl-N-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenylamino]-1-phenylmethylene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid methyl ester launched 2014….Idiopathic pulmonary fibrosis  chinese,…

FDA Approves Blincyto (blinatumomab) for Precursor B-Cell Acute Lymphoblastic Leukemia

Blinatumomab linking a T cell to a malignant B cell.

FDA Approves Blincyto (blinatumomab) for Precursor B-Cell Acute Lymphoblastic Leukemia

// // //

December 3, 2014 — The U.S. Food and Drug Administration today approved Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia (B-cell ALL), an uncommon form…

The U.S. Food and Drug Administration approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF).

Nintedanib

FDA approves Ofev to treat idiopathic pulmonary fibrosis

10/15/2014 

The U.S. Food and Drug Administration today approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF).

read at

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418994.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

see synthesis

http://newdrugapprovals.org/2014/05/2…